Skip to main content
. Author manuscript; available in PMC: 2009 Jul 22.
Published in final edited form as: N Engl J Med. 2008 Aug 27;359(12):1225–1237. doi: 10.1056/NEJMoa0804593

Figure 3. Effect of Telmisartan on the Risk of Stroke or Major Cardiovascular Events in Prespecified Subgroups.

Figure 3

Shown are the effects telmisartan on the risks of stroke (Panel A) and major cardiovascular events (Panel B) in prespecified subgroups and in patients who underwent randomization either 10 days or less after the qualifying stroke or more than 10 days after the qualifying stroke. The sizes of the squares are proportional to the numbers of events. For details on calculation of the stroke risk score, see the Supplementary Appendix.

HHS Vulnerability Disclosure